THE UNITED STATES PHARMACOPEIAL CONVENTION — Lobbying Disclosure | Poliscope

THE UNITED STATES PHARMACOPEIAL CONVENTION

View full entity profile (contributions, contracts, SEC) →

This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.

Lobbying Spend

$5.7M

Filings

Firms Hired

Active Period

2008–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	$480,000	7	2
2025	$360,000	13	3
2024	$240,000	4	1
2023	$220,000	4	1
2022	$320,000	4	1
2021	$370,000	4	1
2020	$420,000	4	1
2019	$450,000	4	1
2018	$270,000	4	1
2017	$450,000	4	1
2016	$440,000	4	1
2015	$60,000	4	1
2014	$80,000	4	1
2013	$140,000	4	1
2012	$220,000	4	1
2011	$250,000	4	1
2010	$320,000	4	1
2009	$355,000	4	1
2008	$230,000	4	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
THE UNITED STATES PHARMACOPEIAL CONVENTION	$5,675,000	76
CORNERSTONE GOVERNMENT AFFAIRS, INC.	—	7
HORIZON GOVERNMENT AFFAIRS	—	5

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
SENATE	81
HOUSE OF REPRESENTATIVES	80
Food & Drug Administration (FDA)	24
Government Accountability Office (GAO)	20
Health & Human Services, Dept of (HHS)	16
Commerce, Dept of (DOC)	11
Centers For Medicare and Medicaid Services (CMS)	10
Natl Institutes of Health (NIH)	5
State, Dept of (DOS)	5
Congressional Budget Office (CBO)	4
Centers For Disease Control & Prevention (CDC)	3
Natl Institute of Standards & Technology (NIST)	3
Office of Management & Budget (OMB)	3
U.S. Agency for International Development (USAID)	3
Agriculture, Dept of (USDA)	2
President of the U.S.	2
Veterans Affairs, Dept of (VA)	2
Agency for Healthcare Research & Quality (AHRQ)	1
Treasury, Dept of	1
U.S. Trade Representative (USTR)	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	64
Pharmacy	Pharmacy	49
Food Industry (safety, labeling, etc.)	Food Industry (safety, labeling, etc.)	36
Consumer Issues/Safety/Products	Consumer Issues/Safety/Products	23
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	7
Medicare/Medicaid	Medicare/Medicaid	7
Budget/Appropriations	Budget/Appropriations	6
Trade (domestic/foreign)	Trade (domestic/foreign)	6
Defense	Defense	4
Chemicals/Chemical Industry	Chemicals/Chemical Industry	3
Agriculture	Agriculture	1
Science/Technology	Science/Technology	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 4191119th Congress

MAPS Act

2026 · third_quarter · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION

Open original LDA filing ↗

Cited source text and reported amounts

S. 1784, H.R. 4191 - Mapping America's Pharmaceutical Supply (MAPS) Act: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling. Issues related to strengthening the resiliency of the U.S. medical supply chain. Issues related to questions for the record (QFRs) for Administration for Strategic Preparedness and Response and Food and Drug Administration nominees.

Client expense: $120,000 · Firm income: —

Matched citations: H.R. 4191

H.R. 4779119th Congress

National Security, Department of State, and Related Programs Appropriations Act, 2026

2026 · third_quarter · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 5304, S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience. H.R. 4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.

Client expense: $120,000 · Firm income: —

Matched citations: H.R. 4779

H.R. 5304119th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

2026 · third_quarter · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 5304, S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience. H.R. 4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.

Client expense: $120,000 · Firm income: —

Matched citations: H.R. 5304

H.R. 8800119th Congress

National Defense Authorization Act for Fiscal Year 2027

2026 · third_quarter · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION

Open original LDA filing ↗

Cited source text and reported amounts

S. 2296 - National Defense Authorization Act for Fiscal Year 2026; H.R. 8800 - National Defense Authorization Act for Fiscal Year 2027: Provisions related to supply chain resilience.

Client expense: $120,000 · Firm income: —

Matched citations: H.R. 8800

Show 21 more cited filings

S. 1784119th Congress

MAPS Act

2026 · third_quarter · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION

Open original LDA filing ↗

Cited source text and reported amounts

S. 1784, H.R. 4191 - Mapping America's Pharmaceutical Supply (MAPS) Act: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling. Issues related to strengthening the resiliency of the U.S. medical supply chain. Issues related to questions for the record (QFRs) for Administration for Strategic Preparedness and Response and Food and Drug Administration nominees.

Client expense: $120,000 · Firm income: —

Matched citations: S. 1784

S. 2296119th Congress

National Defense Authorization Act for Fiscal Year 2026

2026 · third_quarter · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION

Open original LDA filing ↗

Cited source text and reported amounts

S. 2296 - National Defense Authorization Act for Fiscal Year 2026; H.R. 8800 - National Defense Authorization Act for Fiscal Year 2027: Provisions related to supply chain resilience.

Client expense: $120,000 · Firm income: —

Matched citations: S. 2296

S. 2587119th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

2026 · third_quarter · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 5304, S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience. H.R. 4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.

Client expense: $120,000 · Firm income: —

Matched citations: S. 2587

S. 3788119th Congress

CLEAR LABELS Act

2026 · third_quarter · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION

Open original LDA filing ↗

Cited source text and reported amounts

S. 1784, H.R. 4191 - Mapping America's Pharmaceutical Supply (MAPS) Act: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling. Issues related to strengthening the resiliency of the U.S. medical supply chain. Issues related to questions for the record (QFRs) for Administration for Strategic Preparedness and Response and Food and Drug Administration nominees.

Client expense: $120,000 · Firm income: —

Matched citations: S. 3788

H.R. 4191119th Congress

MAPS Act

2026 · first_quarter · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION

Open original LDA filing ↗

Cited source text and reported amounts

S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling.

Client expense: $130,000 · Firm income: —

Matched citations: H.R. 4191

S. 1784119th Congress

MAPS Act

2026 · first_quarter · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION

Open original LDA filing ↗

Cited source text and reported amounts

S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling.

Client expense: $130,000 · Firm income: —

Matched citations: S. 1784

S. 3788119th Congress

CLEAR LABELS Act

2026 · first_quarter · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION

Open original LDA filing ↗

Cited source text and reported amounts

S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling.

Client expense: $130,000 · Firm income: —

Matched citations: S. 3788

H.R. 4191119th Congress

MAPS Act

2026 · second_quarter · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION

Open original LDA filing ↗

Cited source text and reported amounts

S. 1784, H.R. 4191 - Mapping America's Pharmaceutical Supply (MAPS) Act - Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling. Issues related to strengthening the resiliency of the U.S. medical supply chain.

Client expense: $120,000 · Firm income: —

Matched citations: H.R. 4191

H.R. 4779119th Congress

National Security, Department of State, and Related Programs Appropriations Act, 2026

2026 · second_quarter · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 5304, S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience. H.R. 4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.

Client expense: $120,000 · Firm income: —

Matched citations: H.R. 4779

H.R. 5304119th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

2026 · second_quarter · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 5304, S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience. H.R. 4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.

Client expense: $120,000 · Firm income: —

Matched citations: H.R. 5304

H.R. 8800119th Congress

National Defense Authorization Act for Fiscal Year 2027

2026 · second_quarter · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION

Open original LDA filing ↗

Cited source text and reported amounts

S. 2296 - National Defense Authorization Act for Fiscal Year 2026; H.R. 8800 - National Defense Authorization Act for Fiscal Year 2027: Provisions related to supply chain resilience.

Client expense: $120,000 · Firm income: —

Matched citations: H.R. 8800

S. 1784119th Congress

MAPS Act

2026 · second_quarter · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION

Open original LDA filing ↗

Cited source text and reported amounts

S. 1784, H.R. 4191 - Mapping America's Pharmaceutical Supply (MAPS) Act - Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling. Issues related to strengthening the resiliency of the U.S. medical supply chain.

Client expense: $120,000 · Firm income: —

Matched citations: S. 1784

S. 2296119th Congress

National Defense Authorization Act for Fiscal Year 2026

2026 · second_quarter · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION

Open original LDA filing ↗

Cited source text and reported amounts

S. 2296 - National Defense Authorization Act for Fiscal Year 2026; H.R. 8800 - National Defense Authorization Act for Fiscal Year 2027: Provisions related to supply chain resilience.

Client expense: $120,000 · Firm income: —

Matched citations: S. 2296

S. 2587119th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

2026 · second_quarter · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 5304, S. 2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience. H.R. 4779 - National Security, Department of State, and Related Programs Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.

Client expense: $120,000 · Firm income: —

Matched citations: S. 2587

S. 3788119th Congress

CLEAR LABELS Act

2026 · second_quarter · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION

Open original LDA filing ↗

Cited source text and reported amounts

S. 1784, H.R. 4191 - Mapping America's Pharmaceutical Supply (MAPS) Act - Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling. Issues related to strengthening the resiliency of the U.S. medical supply chain.

Client expense: $120,000 · Firm income: —

Matched citations: S. 3788

H.R. 4191119th Congress

MAPS Act

2026 · first_quarter · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION

Open original LDA filing ↗

Cited source text and reported amounts

S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling.

Client expense: $110,000 · Firm income: —

Matched citations: H.R. 4191

S. 1784119th Congress

MAPS Act

2026 · first_quarter · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION

Open original LDA filing ↗

Cited source text and reported amounts

S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling.

Client expense: $110,000 · Firm income: —

Matched citations: S. 1784

S. 3788119th Congress

CLEAR LABELS Act

2026 · first_quarter · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION

Open original LDA filing ↗

Cited source text and reported amounts

S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling.

Client expense: $110,000 · Firm income: —

Matched citations: S. 3788

H.R. 4191119th Congress

MAPS Act

2025 · fourth_quarter · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION

Open original LDA filing ↗

Cited source text and reported amounts

S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain security and resilience and drug shortages.

Client expense: $100,000 · Firm income: —

Matched citations: H.R. 4191

H.R. 4779119th Congress

National Security, Department of State, and Related Programs Appropriations Act, 2026

2025 · fourth_quarter · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 5304, S.2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; H.R. 4779 National Security, Department of State, and Related Programs Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.

Client expense: $100,000 · Firm income: —

Matched citations: H.R. 4779

H.R. 5304119th Congress

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026

2025 · fourth_quarter · Firm: THE UNITED STATES PHARMACOPEIAL CONVENTION

Open original LDA filing ↗

Cited source text and reported amounts

H.R. 5304, S.2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026; H.R. 4779 National Security, Department of State, and Related Programs Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.

Client expense: $100,000 · Firm income: —

Matched citations: H.R. 5304

Source: Senate LDA